A new lab sensor finds tiny cell bubbles in blood samples
Original title: Engineering Carbon Nanotube Quantum Well Defects With Recognition Tripeptides for Optical Detection of Extracellular Vesicles in Plasma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on lab samples, not in people.
The short version
Scientists built a tiny sensor that can spot cell bubbles in blood samples in the lab.
What was studied. Cells shed tiny bubbles that carry proteins from the cell surface. Researchers built a sensor from a carbon tube with a small protein piece attached. They tested it on human blood plasma mixed with bubbles from glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary cells, ovarian cancer cells, and normal skin cells.
What they found. The sensor found three kinds of surface proteins on the bubbles, even at very low amounts. It picked up bubbles from all three cell types. Bubbles from the normal skin cells gave about the same signal as bubbles from the cancer cells. A separate protein test agreed with that result.
What this means, and what it doesn't
What it could mean: This is a step toward better ways to study cell bubbles in blood. For now it is only a lab tool, not a test a doctor can order. It also cannot tell cancer bubbles apart from normal ones, since both gave the same signal.
What it doesn't mean: This does not mean there is a new blood test for brain tumors. No patients were treated or diagnosed with it. The work was done on lab samples, not in people, so it is very early. It is not a treatment and it is not a cure.
Source: PubMed, October 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.